These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 18516436)

  • 1. Use of topical dorzolamide for patients with X-linked juvenile retinoschisis: case report.
    Bastos AL; Freitas Bde P; Villas Boas O; Ramiro AC
    Arq Bras Oftalmol; 2008; 71(2):286-90. PubMed ID: 18516436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of sustained topical dorzolamide therapy for cystic macular lesions in patients with X-linked retinoschisis.
    Genead MA; Fishman GA; Walia S
    Arch Ophthalmol; 2010 Feb; 128(2):190-7. PubMed ID: 20142541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dramatic response to topical dorzolamide in X-linked retinoschisis.
    Thangavel R; Surve A; Azad S; Kumar V
    Indian J Ophthalmol; 2020 Jul; 68(7):1466-1467. PubMed ID: 32587200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A combination of topical and systemic carbonic anhydrase in the treatment of chromosome X-linked retinoschisis.
    Rocha Cabrera P; Pareja Ríos AC; Cordovés Dorta L; Mantolán Sarmiento C; Serrano García MA
    Arch Soc Esp Oftalmol; 2014 Aug; 89(8):320-3. PubMed ID: 24269421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. STELLATE NONHEREDITARY IDIOPATHIC FOVEOMACULAR RETINOSCHISIS: RESPONSE TO TOPICAL DORZOLAMIDE THERAPY.
    Ajlan RS; Hammamji KS
    Retin Cases Brief Rep; 2019; 13(4):364-366. PubMed ID: 28557864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. X-linked retinoschisis maculopathy treated with topical dorzolamide, and relationship to genotype.
    Khandhadia S; Trump D; Menon G; Lotery AJ
    Eye (Lond); 2011 Jul; 25(7):922-8. PubMed ID: 21527955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of dorzolamide for patients with X-linked retinoschisis.
    Apushkin MA; Fishman GA
    Retina; 2006 Sep; 26(7):741-5. PubMed ID: 16963845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and Genetic Study of X-Linked Juvenile Retinoschisis in the Czech Population.
    Kousal B; Hlavata L; Vlaskova H; Dvorakova L; Brichova M; Dubska Z; Langrova H; Vincent AL; Dudakova L; Liskova P
    Genes (Basel); 2021 Nov; 12(11):. PubMed ID: 34828422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation of response to treatment with dorzolamide in X-linked retinoschisis to the mechanism of functional loss in retinoschisin.
    Walia S; Fishman GA; Molday RS; Dyka FM; Kumar NM; Ehlinger MA; Stone EM
    Am J Ophthalmol; 2009 Jan; 147(1):111-115.e1. PubMed ID: 18834580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dramatic regression of macular and peripheral retinoschisis with dorzolamide 2 % in X-linked retinoschisis: a case report.
    Sadaka A; Sisk RA
    J Med Case Rep; 2016 Jun; 10(1):142. PubMed ID: 27246168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paradoxical Anatomic Response to Topical Carbonic Anhydrase Inhibitor in X-linked Retinoschisis.
    Menke B; Walters A; Payne JF
    Ophthalmic Surg Lasers Imaging Retina; 2018 Feb; 49(2):142-144. PubMed ID: 29443366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of cystic cavities in X-linked juvenile retinoschisis: The first sequential cross-over treatment regimen with dorzolamide.
    Coussa RG; Kapusta MA
    Am J Ophthalmol Case Rep; 2017 Dec; 8():1-3. PubMed ID: 29260104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TOPICAL CARBONIC ANHYDRASE INHIBITORS IN THE LONG-TERM TREATMENT OF JUVENILE X-LINKED RETINOSCHISIS.
    Schmitt MA; Wang K; DeBenedictis MJ; Traboulsi EI
    Retina; 2022 Nov; 42(11):2176-2183. PubMed ID: 35982512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of Carbonic Anhydrase Inhibitors on Cystoid Fluid Collections and Visual Acuity in Patients with X-Linked Retinoschisis.
    Hensman J; Hahn LC; van Schooneveld MJ; Diederen RMH; Ten Brink JB; Florijn RJ; Bergen AA; Strubbe I; Heutinck P; van Genderen MM; van den Born LI; Thiadens AA; de Zaeytijd J; Leroy BP; Hoyng CB; Boon CJF
    Ophthalmol Retina; 2024 Jun; 8(6):600-606. PubMed ID: 38104928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical brinzolamide for foveal schisis in juvenile retinoschisis.
    Yang FP; Willyasti K; Leo SW
    J AAPOS; 2013 Apr; 17(2):225-7. PubMed ID: 23541677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic effect of prolonged treatment with topical dorzolamide for cystoid macular oedema in patients with retinitis pigmentosa.
    Ikeda Y; Yoshida N; Notomi S; Murakami Y; Hisatomi T; Enaida H; Ishibashi T
    Br J Ophthalmol; 2013 Sep; 97(9):1187-91. PubMed ID: 23782868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. POSSIBLE EFFICACY OF TOPICAL DORZOLAMIDE IN THE TREATMENT OF PACLITAXEL-RELATED CYSTOID MACULAR EDEMA.
    Dwivedi R; Tiroumal S
    Retin Cases Brief Rep; 2018 Winter; 12(1):75-79. PubMed ID: 27749791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. USE OF A CARBONIC ANHYDRASE INHIBITOR IN X-LINKED RETINOSCHISIS: Effect on Cystic-Appearing Macular Lesions and Visual Acuity.
    Andreuzzi P; Fishman GA; Anderson RJ
    Retina; 2017 Aug; 37(8):1555-1561. PubMed ID: 27828908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diurnal variations of foveoschisis by optical coherence tomography in patients with RS1 X-linked juvenile retinoschisis.
    Abalem MF; Musch DC; Birch DG; Pennesi ME; Heckenlively JR; Jayasundera T
    Ophthalmic Genet; 2018 Aug; 39(4):437-442. PubMed ID: 29902095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo imaging reveals novel aspects of retinal disease progression in Rs1h(-/Y) mice but no therapeutic effect of carbonic anhydrase inhibition.
    Zhour A; Bolz S; Grimm C; Willmann G; Schatz A; Weber BH; Zrenner E; Fischer MD
    Vet Ophthalmol; 2012 Sep; 15 Suppl 2():123-33. PubMed ID: 22672048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.